fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Showing products 1–24 of 36. More products

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Carvedilol

All strengths: Limited Use, Reason for Use code 183 required; same patient cost rules

Shared coverage and patient cost rules
StatusLimited Use, Reason for Use code 183 required
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays: • ODB senior: $100/program-year deductible • Then up to $6.11 per prescription • Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]

Auro-Carvedilol · DIN 02418495 · 3.125 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Carvedilol · DIN 02418495 Manufacturer: Auro Pharma Inc.; listing date 2014-04-30 Daily cost (source): $0.4120 Health Canada: Marketed since 2014-02-06 · brand AURO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Auro-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02418495)

Source record
DIN 02418495: Auro-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id AUR Source form: Tab; strength: 3.125mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02418495 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90306
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060 Carvedilol · DIN 02248752 · $0.2060 Carvedilol · DIN 02364913 · $0.2060 Coreg · DIN 02229650 · not recorded Jamp-Carvedilol · DIN 02368897 · $0.2060 PMS-Carvedilol · DIN 02245914 · $0.2060 Ran-Carvedilol · DIN 02268027 · $0.2060 Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended September 15, 2023); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02418495
Shortage record checked October 6, 2026

Carvedilol · DIN 02248752 · 3.125 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02248752 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2010-03-02 Daily cost (source): $0.4120 Health Canada: Marketed since 2018-10-24 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248752)

Source record
DIN 02248752: Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id SIV Source form: Tab; strength: 3.125mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248752 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73120
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060 Auro-Carvedilol · DIN 02418495 · $0.2060 Carvedilol · DIN 02364913 · $0.2060 Coreg · DIN 02229650 · not recorded Jamp-Carvedilol · DIN 02368897 · $0.2060 PMS-Carvedilol · DIN 02245914 · $0.2060 Ran-Carvedilol · DIN 02268027 · $0.2060 Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended May 20, 2020); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02248752
Shortage record checked October 6, 2026

Carvedilol · DIN 02364913 · 3.125 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02364913 Manufacturer: Sanis Health Inc.; listing date 2011-10-25 Daily cost (source): $0.4120 Health Canada: Marketed since 2013-10-12 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02364913)

Source record
DIN 02364913: Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id SAI Source form: Tab; strength: 3.125mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02364913 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84979
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060 Auro-Carvedilol · DIN 02418495 · $0.2060 Carvedilol · DIN 02248752 · $0.2060 Coreg · DIN 02229650 · not recorded Jamp-Carvedilol · DIN 02368897 · $0.2060 PMS-Carvedilol · DIN 02245914 · $0.2060 Ran-Carvedilol · DIN 02268027 · $0.2060 Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended November 25, 2024); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02364913
Shortage record checked October 6, 2026

Jamp-Carvedilol · DIN 02368897 · 3.125 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Jamp-Carvedilol · DIN 02368897 Manufacturer: Jamp Pharma Corporation; listing date 2012-08-27 Daily cost (source): $0.4120 Health Canada: Marketed since 2022-01-12 · brand JAMP-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Jamp-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02368897)

Source record
DIN 02368897: Jamp-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id JPC Source form: Tab; strength: 3.125mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02368897 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85386
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060 Auro-Carvedilol · DIN 02418495 · $0.2060 Carvedilol · DIN 02248752 · $0.2060 Carvedilol · DIN 02364913 · $0.2060 Coreg · DIN 02229650 · not recorded PMS-Carvedilol · DIN 02245914 · $0.2060 Ran-Carvedilol · DIN 02268027 · $0.2060 Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended August 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02368897
Shortage record checked October 6, 2026

PMS-Carvedilol · DIN 02245914 · 3.125 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
PMS-Carvedilol · DIN 02245914 Manufacturer: Pharmascience Inc.; listing date 2004-04-06 Daily cost (source): $0.4120 Health Canada: Marketed since 2003-08-04 · brand PMS-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Pharmascience inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

PMS-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245914)

Source record
DIN 02245914: PMS-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id PMS Source form: Tab; strength: 3.125mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245914 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70034
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060 Auro-Carvedilol · DIN 02418495 · $0.2060 Carvedilol · DIN 02248752 · $0.2060 Carvedilol · DIN 02364913 · $0.2060 Coreg · DIN 02229650 · not recorded Jamp-Carvedilol · DIN 02368897 · $0.2060 Ran-Carvedilol · DIN 02268027 · $0.2060 Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended June 26, 2018); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02245914
Shortage record checked October 6, 2026

Ratio-Carvedilol · DIN 02252309 · 3.125 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Ratio-Carvedilol · DIN 02252309 Manufacturer: Ratiopharm Inc.; listing date 2004-07-20 Daily cost (source): $0.4120 Health Canada: Marketed since 2018-01-09 · brand TEVA-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Ratio-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02252309)

Source record
DIN 02252309: Ratio-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id RPH Source form: Tab; strength: 3.125mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02252309 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73718
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060 Auro-Carvedilol · DIN 02418495 · $0.2060 Carvedilol · DIN 02248752 · $0.2060 Carvedilol · DIN 02364913 · $0.2060 Coreg · DIN 02229650 · not recorded Jamp-Carvedilol · DIN 02368897 · $0.2060 PMS-Carvedilol · DIN 02245914 · $0.2060 Ran-Carvedilol · DIN 02268027 · $0.2060
Shortage status: resolved shortage (ended May 5, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02252309
Shortage record checked October 6, 2026

Auro-Carvedilol · DIN 02418509 · 6.25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Carvedilol · DIN 02418509 Manufacturer: Auro Pharma Inc.; listing date 2014-04-30 Daily cost (source): $0.4120 Health Canada: Marketed since 2014-02-06 · brand AURO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Auro-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02418509)

Source record
DIN 02418509: Auro-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id AUR Source form: Tab; strength: 6.25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02418509 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90307
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060 Carvedilol · DIN 02248753 · $0.2060 Carvedilol · DIN 02364921 · $0.2060 Coreg · DIN 02229651 · not recorded Jamp-Carvedilol · DIN 02368900 · $0.2060 PMS-Carvedilol · DIN 02245915 · $0.2060 Ran-Carvedilol · DIN 02268035 · $0.2060 Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended March 29, 2022); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02418509
Shortage record checked October 6, 2026

Carvedilol · DIN 02248753 · 6.25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02248753 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2010-03-02 Daily cost (source): $0.4120 Health Canada: Marketed since 2018-07-06 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248753)

Source record
DIN 02248753: Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id SIV Source form: Tab; strength: 6.25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248753 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73121
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060 Auro-Carvedilol · DIN 02418509 · $0.2060 Carvedilol · DIN 02364921 · $0.2060 Coreg · DIN 02229651 · not recorded Jamp-Carvedilol · DIN 02368900 · $0.2060 PMS-Carvedilol · DIN 02245915 · $0.2060 Ran-Carvedilol · DIN 02268035 · $0.2060 Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended September 3, 2018); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02248753
Shortage record checked October 6, 2026

Carvedilol · DIN 02364921 · 6.25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02364921 Manufacturer: Sanis Health Inc.; listing date 2011-10-25 Daily cost (source): $0.4120 Health Canada: Marketed since 2013-10-12 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02364921)

Source record
DIN 02364921: Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id SAI Source form: Tab; strength: 6.25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02364921 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84980
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060 Auro-Carvedilol · DIN 02418509 · $0.2060 Carvedilol · DIN 02248753 · $0.2060 Coreg · DIN 02229651 · not recorded Jamp-Carvedilol · DIN 02368900 · $0.2060 PMS-Carvedilol · DIN 02245915 · $0.2060 Ran-Carvedilol · DIN 02268035 · $0.2060 Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended August 18, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02364921
Shortage record checked October 6, 2026

Jamp-Carvedilol · DIN 02368900 · 6.25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Jamp-Carvedilol · DIN 02368900 Manufacturer: Jamp Pharma Corporation; listing date 2012-08-27 Daily cost (source): $0.4120 Health Canada: Marketed since 2022-01-12 · brand JAMP-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Jamp-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02368900)

Source record
DIN 02368900: Jamp-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id JPC Source form: Tab; strength: 6.25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02368900 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85387
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060 Auro-Carvedilol · DIN 02418509 · $0.2060 Carvedilol · DIN 02248753 · $0.2060 Carvedilol · DIN 02364921 · $0.2060 Coreg · DIN 02229651 · not recorded PMS-Carvedilol · DIN 02245915 · $0.2060 Ran-Carvedilol · DIN 02268035 · $0.2060 Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended March 27, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02368900
Shortage record checked October 6, 2026

PMS-Carvedilol · DIN 02245915 · 6.25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
PMS-Carvedilol · DIN 02245915 Manufacturer: Pharmascience Inc.; listing date 2004-04-06 Daily cost (source): $0.4120 Health Canada: Marketed since 2003-08-04 · brand PMS-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Pharmascience inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

PMS-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245915)

Source record
DIN 02245915: PMS-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id PMS Source form: Tab; strength: 6.25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245915 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70035
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060 Auro-Carvedilol · DIN 02418509 · $0.2060 Carvedilol · DIN 02248753 · $0.2060 Carvedilol · DIN 02364921 · $0.2060 Coreg · DIN 02229651 · not recorded Jamp-Carvedilol · DIN 02368900 · $0.2060 Ran-Carvedilol · DIN 02268035 · $0.2060 Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended June 26, 2018); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02245915
Shortage record checked October 6, 2026

Ratio-Carvedilol · DIN 02252317 · 6.25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Ratio-Carvedilol · DIN 02252317 Manufacturer: Ratiopharm Inc.; listing date 2004-07-20 Daily cost (source): $0.4120 Health Canada: Marketed since 2018-01-09 · brand TEVA-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Ratio-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02252317)

Source record
DIN 02252317: Ratio-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id RPH Source form: Tab; strength: 6.25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02252317 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73719
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060 Auro-Carvedilol · DIN 02418509 · $0.2060 Carvedilol · DIN 02248753 · $0.2060 Carvedilol · DIN 02364921 · $0.2060 Coreg · DIN 02229651 · not recorded Jamp-Carvedilol · DIN 02368900 · $0.2060 PMS-Carvedilol · DIN 02245915 · $0.2060 Ran-Carvedilol · DIN 02268035 · $0.2060
Shortage status: resolved shortage (ended May 5, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02252317
Shortage record checked October 6, 2026

Auro-Carvedilol · DIN 02418517 · 12.5 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Carvedilol · DIN 02418517 Manufacturer: Auro Pharma Inc.; listing date 2014-04-30 Daily cost (source): $0.4120 Health Canada: Marketed since 2014-02-06 · brand AURO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Auro-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02418517)

Source record
DIN 02418517: Auro-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id AUR Source form: Tab; strength: 12.5mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02418517 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90308
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060 Carvedilol · DIN 02248754 · $0.2060 Carvedilol · DIN 02364948 · $0.2060 Coreg · DIN 02229652 · not recorded Jamp-Carvedilol · DIN 02368919 · $0.2060 PMS-Carvedilol · DIN 02245916 · $0.2060 Ran-Carvedilol · DIN 02268043 · $0.2060 Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended October 28, 2024); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02418517
Shortage record checked October 6, 2026

Carvedilol · DIN 02248754 · 12.5 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02248754 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2010-03-02 Daily cost (source): $0.4120 Health Canada: Marketed since 2018-07-06 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248754)

Source record
DIN 02248754: Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id SIV Source form: Tab; strength: 12.5mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248754 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73122
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060 Auro-Carvedilol · DIN 02418517 · $0.2060 Carvedilol · DIN 02364948 · $0.2060 Coreg · DIN 02229652 · not recorded Jamp-Carvedilol · DIN 02368919 · $0.2060 PMS-Carvedilol · DIN 02245916 · $0.2060 Ran-Carvedilol · DIN 02268043 · $0.2060 Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended August 12, 2019); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02248754
Shortage record checked October 6, 2026

Carvedilol · DIN 02364948 · 12.5 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02364948 Manufacturer: Sanis Health Inc.; listing date 2011-10-25 Daily cost (source): $0.4120 Health Canada: Marketed since 2013-10-12 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02364948)

Source record
DIN 02364948: Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id SAI Source form: Tab; strength: 12.5mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02364948 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84981
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060 Auro-Carvedilol · DIN 02418517 · $0.2060 Carvedilol · DIN 02248754 · $0.2060 Coreg · DIN 02229652 · not recorded Jamp-Carvedilol · DIN 02368919 · $0.2060 PMS-Carvedilol · DIN 02245916 · $0.2060 Ran-Carvedilol · DIN 02268043 · $0.2060 Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended April 22, 2024); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02364948
Shortage record checked October 6, 2026

Jamp-Carvedilol · DIN 02368919 · 12.5 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Jamp-Carvedilol · DIN 02368919 Manufacturer: Jamp Pharma Corporation; listing date 2012-08-27 Daily cost (source): $0.4120 Health Canada: Marketed since 2022-01-12 · brand JAMP-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Jamp-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02368919)

Source record
DIN 02368919: Jamp-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id JPC Source form: Tab; strength: 12.5mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02368919 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85388
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060 Auro-Carvedilol · DIN 02418517 · $0.2060 Carvedilol · DIN 02248754 · $0.2060 Carvedilol · DIN 02364948 · $0.2060 Coreg · DIN 02229652 · not recorded PMS-Carvedilol · DIN 02245916 · $0.2060 Ran-Carvedilol · DIN 02268043 · $0.2060 Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended July 13, 2022); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02368919
Shortage record checked October 6, 2026

PMS-Carvedilol · DIN 02245916 · 12.5 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
PMS-Carvedilol · DIN 02245916 Manufacturer: Pharmascience Inc.; listing date 2004-04-06 Daily cost (source): $0.4120 Health Canada: Marketed since 2003-08-04 · brand PMS-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Pharmascience inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

PMS-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245916)

Source record
DIN 02245916: PMS-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id PMS Source form: Tab; strength: 12.5mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245916 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70036
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060 Auro-Carvedilol · DIN 02418517 · $0.2060 Carvedilol · DIN 02248754 · $0.2060 Carvedilol · DIN 02364948 · $0.2060 Coreg · DIN 02229652 · not recorded Jamp-Carvedilol · DIN 02368919 · $0.2060 Ran-Carvedilol · DIN 02268043 · $0.2060 Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended July 12, 2018); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02245916
Shortage record checked October 6, 2026

Ratio-Carvedilol · DIN 02252325 · 12.5 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Ratio-Carvedilol · DIN 02252325 Manufacturer: Ratiopharm Inc.; listing date 2004-07-20 Daily cost (source): $0.4120 Health Canada: Marketed since 2018-01-09 · brand TEVA-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Ratio-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02252325)

Source record
DIN 02252325: Ratio-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id RPH Source form: Tab; strength: 12.5mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02252325 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73720
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060 Auro-Carvedilol · DIN 02418517 · $0.2060 Carvedilol · DIN 02248754 · $0.2060 Carvedilol · DIN 02364948 · $0.2060 Coreg · DIN 02229652 · not recorded Jamp-Carvedilol · DIN 02368919 · $0.2060 PMS-Carvedilol · DIN 02245916 · $0.2060 Ran-Carvedilol · DIN 02268043 · $0.2060
Shortage status: resolved shortage (ended May 5, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02252325
Shortage record checked October 6, 2026

Auro-Carvedilol · DIN 02418525 · 25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Carvedilol · DIN 02418525 Manufacturer: Auro Pharma Inc.; listing date 2014-04-30 Daily cost (source): $0.4120 Health Canada: Marketed since 2014-02-06 · brand AURO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Auro-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02418525)

Source record
DIN 02418525: Auro-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id AUR Source form: Tab; strength: 25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02418525 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90309
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060 Carvedilol · DIN 02248755 · $0.2060 Carvedilol · DIN 02364956 · $0.2060 Coreg · DIN 02229653 · not recorded Jamp-Carvedilol · DIN 02368927 · $0.2060 PMS-Carvedilol · DIN 02245917 · $0.2060 Ran-Carvedilol · DIN 02268051 · $0.2060 Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended October 28, 2024); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02418525
Shortage record checked October 6, 2026

Carvedilol · DIN 02248755 · 25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02248755 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2010-03-02 Daily cost (source): $0.4120 Health Canada: Marketed since 2018-07-06 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248755)

Source record
DIN 02248755: Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id SIV Source form: Tab; strength: 25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248755 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73123
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060 Auro-Carvedilol · DIN 02418525 · $0.2060 Carvedilol · DIN 02364956 · $0.2060 Coreg · DIN 02229653 · not recorded Jamp-Carvedilol · DIN 02368927 · $0.2060 PMS-Carvedilol · DIN 02245917 · $0.2060 Ran-Carvedilol · DIN 02268051 · $0.2060 Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended September 3, 2018); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02248755
Shortage record checked October 6, 2026

Carvedilol · DIN 02364956 · 25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02364956 Manufacturer: Sanis Health Inc.; listing date 2011-10-25 Daily cost (source): $0.4120 Health Canada: Marketed since 2013-10-12 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02364956)

Source record
DIN 02364956: Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id SAI Source form: Tab; strength: 25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02364956 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84982
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060 Auro-Carvedilol · DIN 02418525 · $0.2060 Carvedilol · DIN 02248755 · $0.2060 Coreg · DIN 02229653 · not recorded Jamp-Carvedilol · DIN 02368927 · $0.2060 PMS-Carvedilol · DIN 02245917 · $0.2060 Ran-Carvedilol · DIN 02268051 · $0.2060 Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended October 1, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02364956
Shortage record checked October 6, 2026

Jamp-Carvedilol · DIN 02368927 · 25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Jamp-Carvedilol · DIN 02368927 Manufacturer: Jamp Pharma Corporation; listing date 2012-08-27 Daily cost (source): $0.4120 Health Canada: Marketed since 2022-01-12 · brand JAMP-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Jamp-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02368927)

Source record
DIN 02368927: Jamp-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id JPC Source form: Tab; strength: 25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02368927 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85389
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060 Auro-Carvedilol · DIN 02418525 · $0.2060 Carvedilol · DIN 02248755 · $0.2060 Carvedilol · DIN 02364956 · $0.2060 Coreg · DIN 02229653 · not recorded PMS-Carvedilol · DIN 02245917 · $0.2060 Ran-Carvedilol · DIN 02268051 · $0.2060 Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended July 13, 2022); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02368927
Shortage record checked October 6, 2026

PMS-Carvedilol · DIN 02245917 · 25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
PMS-Carvedilol · DIN 02245917 Manufacturer: Pharmascience Inc.; listing date 2004-04-06 Daily cost (source): $0.4120 Health Canada: Marketed since 2003-08-04 · brand PMS-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Pharmascience inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

PMS-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245917)

Source record
DIN 02245917: PMS-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id PMS Source form: Tab; strength: 25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245917 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70037
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060 Auro-Carvedilol · DIN 02418525 · $0.2060 Carvedilol · DIN 02248755 · $0.2060 Carvedilol · DIN 02364956 · $0.2060 Coreg · DIN 02229653 · not recorded Jamp-Carvedilol · DIN 02368927 · $0.2060 Ran-Carvedilol · DIN 02268051 · $0.2060 Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended September 16, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02245917
Shortage record checked October 6, 2026

Ratio-Carvedilol · DIN 02252333 · 25 mg · tablet

Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Ratio-Carvedilol · DIN 02252333 Manufacturer: Ratiopharm Inc.; listing date 2004-07-20 Daily cost (source): $0.4120 Health Canada: Marketed since 2018-01-09 · brand TEVA-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Ratio-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02252333)

Source record
DIN 02252333: Ratio-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id RPH Source form: Tab; strength: 25mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02252333 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73721
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060 Auro-Carvedilol · DIN 02418525 · $0.2060 Carvedilol · DIN 02248755 · $0.2060 Carvedilol · DIN 02364956 · $0.2060 Coreg · DIN 02229653 · not recorded Jamp-Carvedilol · DIN 02368927 · $0.2060 PMS-Carvedilol · DIN 02245917 · $0.2060 Ran-Carvedilol · DIN 02268051 · $0.2060
Shortage status: resolved shortage (ended October 1, 2025); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02252333
Shortage record checked October 6, 2026

Other products in the same Health Canada class (C07A): coverage varies; not interchangeable

  • Acebutolol (Sectral): general benefit, not a benefit
  • Atenolol (Apo-Atenol): general benefit
  • Bisoprolol (Sandoz Bisoprolol Tablets): general benefit, not a benefit
  • Metoprolol (Lopresor SR): general benefit, not a benefit
  • Nadolol (Corgard): general benefit, not a benefit
  • Propranolol (Inderal-LA): general benefit, not a benefit

3 more in the class list below

Other drugs in the same formulary class (24:04 Cardiac Drugs) and how they are covered

Matched class: 24:04 Cardiac Drugs

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Public program routes: ODB 65 and over Covered without a code on the Ontario formulary: ATENOLOL, DIGOXIN, PROPAFENONE HCL Some products covered without a code (check the product listing): ACEBUTOLOL HCL, AMIODARONE HCL, AMLODIPINE, BISOPROLOL FUMARATE, DILTIAZEM HCL, DISOPYRAMIDE, FLECAINIDE ACETATE, METOPROLOL TARTRATE, MEXILETINE HCL, NADOLOL, NIFEDIPINE, PROPRANOLOL, SOTALOL HCL, TIMOLOL MALEATE, VERAPAMIL HCL 24:00 CARDIOVASCULAR DRUGS

RANOLAZINE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg · ER Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 24:00 24:04 Cardiac Drugs

ACEBUTOLOL HCL

· 9 products · Listed, not a benefit (3), General benefit (6) · strengths: 100mg, 200mg, 400mg · Tab

ATENOLOL

· 26 products · General benefit · strengths: 50mg, 100mg · Tab

BISOPROLOL FUMARATE

· 20 products · General benefit (18), Listed, not a benefit (2) · strengths: 1.25mg, 2.5mg, 5mg, 10mg · Tab

METOPROLOL TARTRATE

· 28 products · Listed, not a benefit (6), General benefit (22) · strengths: 100mg, 200mg, 50mg · LA Tab, Tab

NADOLOL

· 8 products · Listed, not a benefit (3), General benefit (5) · strengths: 40mg, 80mg, 160mg · Tab

PROPRANOLOL

· 19 products · Off-Formulary Interchangeable, not an ODB benefit (8), General benefit (7), Listed, not a benefit (4) · strengths: 60mg, 80mg, 120mg, 160mg, 10mg, 20mg, 40mg · LA Cap, Tab

SOTALOL HCL

· 10 products · Listed, not a benefit (2), General benefit (8) · strengths: 80mg, 160mg · Tab

TIMOLOL MALEATE

· 6 products · Listed, not a benefit (3), General benefit (3) · strengths: 5mg, 10mg, 20mg · Tab

NEBIVOLOL HYDROCHLORIDE

· 8 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab

AMIODARONE HCL

· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 200mg · Tab

AMLODIPINE

· 59 products · Limited Use, codes 645, 706 (1), Off-Formulary Interchangeable, not an ODB benefit (12), General benefit (46) · strengths: 1mg/mL, 2.5mg, 5mg, 10mg · Oral Sol, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 24:04 and 9 more
Full class listing Related classes: 24:06 Antilipemic Drugs, 24:08 Hypotensive Drugs (For Diuretics See 40:28), 24:12 Vasodilating Drugs, 24:32 Renin-Angiotensin Aldosterone Inhibitors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS pms-CARVEDILOL (carvedilol) is indicated:  for the treatment of mild, moderate or severe heart failure of ischemic or non-ischemic origin to increase survival and also, to reduce the combined risk of all-cause mortality and cardiovascular or non-cardiovascular hospitalizations In general, pms-CARVEDILOL is used in conjunction with diuretics and an ACE inhibitor, with or without digitalis. pms-CARVEDILOL should be prescribed by a Health professional experienced in the treatment of heart failure. 1.1 Pediatrics Pediatrics (under 18 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use. 1.2 Geriatrics Geriatrics (over 65 years of age): Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness. https://pdf.hres.ca/dpd_pm/00065327.PDF PM date: April 4, 2022 Source product: PMS-CARVEDILOL; DIN 02245914; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.
Program rules and quotes
Public program routes (Ontario context; residency, health-card/OHIP requirements and enrolment must be confirmed from the quoted rules): ODB 65 and over (seniors path) Eligibility: You may qualify for the Ontario Drug Benefit (ODB) program when you turn 65 years old. (ontario.ca, August 18, 2026 ↗) Eligibility: The Ontario Drug Benefit program is for Ontario residents only and prescriptions must be filled in an Ontario pharmacy to be covered. (ontario.ca, August 18, 2026 ↗) Eligibility: Individual annual net income threshold Program year August 1, 2026 to July 31, 2027: $25,480 This applies to a senior who: does not have a spouse has a married spouse with whom they no longer live in a conjugal relationship has a spouse living in a long-term care home or community home for opportunity (ontario.ca, July 2, 2026 ↗) Eligibility: Combined annual net income requirement Program year August 1, 2026 to July 31, 2027: $42,290 This applies to a senior who has a spouse, other than a spouse described. (ontario.ca, July 2, 2026 ↗) Eligibility: See the first-year deductible table. (ontario.ca, August 18, 2026 ↗) What it pays / costs: the first $100 of total prescription costs each program year (August 1 to July 31 the following year) (ontario.ca, August 18, 2026 ↗) What it pays / costs: up to $6.11 for each prescription filled or refilled (after paying the deductible) (ontario.ca, August 18, 2026 ↗) What it pays / costs: Seniors enrolled in the Seniors Co-Payment Program have no annual deductible and a reduced co-payment of up to $2. (ontario.ca, August 18, 2026 ↗) Enrolment: "We will send you a letter about 3 months before your 65th birthday to let you know you will automatically join the Ontario Drug Benefit program on the first day of the month after you turn 65 years old." (ontario.ca, August 18, 2026 ↗) Enrolment: "To enroll in the Seniors Co-Payment Program, a senior must submit an application to that program and qualify under certain income eligibility thresholds." (ontario.ca, August 18, 2026 ↗)
First year on ODB? The deductible depends on birth month
For your first year of Ontario Drug Benefit program eligibility, depending on the month you turn 65, the deductible may be lower than $100. That’s because the amount of the deductible is based on the number of months between your official start date (the first day of the month after you turn 65) and July 31 (the last day of the Ontario Drug Benefit program year). For example, if you turned 65 on April 15, your official start date would be May 1. Counting from May 1 to July 31 your deductible for the first year would be $25. Use this chart below to see what the deductible will be in your first year:
Month you were bornAmount of first-year deductible
July$100.00
August$91.67
September$83.33
October$75.00
November$66.67
December$58.33
January$50.00
February$41.67
March$33.33
April$25.00
May$16.67
June$8.33

Ontario source · 2026-08-18